中瑞医药 (839574.OC)

+ 收藏

财务摘要(报告期)(中瑞医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年中报2022年年报2022年中报
每股指标:
 每股收益 - 基本(元) 0.830.420.400.19
 每股收益 - 稀释(元) 0.830.420.400.19
 每股收益 - 期末股本摊薄(元) 0.830.420.400.19
 每股净资产BPS(元) 4.494.694.274.55
 每股经营活动产生的现金流量净额(元) 1.850.300.18-0.74
 每股营业收入(元) 13.947.4312.035.72
关键比率:
 净资产收益率 - 摊薄(%) 18.369.059.424.12
 净资产收益率 - 加权(%) 17.639.488.643.78
 净资产收益率 - 平均(%) 18.849.488.803.99
 净资产收益率 - 扣除(%) 18.129.069.484.16
 总资产净利率 - 平均(%) 7.533.803.671.69
 总资产报酬率ROA(%) 11.816.066.603.28
 投入资本回报率ROIC(%) 11.575.926.713.23
 销售毛利率(%) 13.3613.2610.509.62
 销售净利率(%) 5.925.723.343.28
 资产负债率(%) 58.1858.1461.8160.26
 资产周转率(倍) 1.270.661.100.52
 销售商品提供劳务收到的现金/营业收入(%) 113.73103.32104.75100.51
 营业利润同比增长率(%) 103.68122.66-50.82-52.83
 营业收入同比增长率(%) 15.8330.040.430.90
 利润总额同比增长率(%) 103.39124.38-51.06-53.22
 归属母公司股东的净利润同比增长率(%) 105.29126.35-51.57-53.76
 扣非后归属母公司股东的净利润同比增长率(%) 101.28124.54-47.38-44.93
 总资产同比增长率(%) -3.88-2.174.1932.38
 总负债同比增长率(%) -9.53-5.6217.8863.85
 净资产同比增长率(%) 5.273.05-12.292.52
利润表摘要:
 营业总收入(元) 600,733,027.65320,348,587.87518,655,377.82246,342,833.48
 营业总成本(元) 544,815,906.32290,177,394.75487,471,153.37233,027,525.74
 营业收入(元) 600,733,027.65320,348,587.87518,655,377.82246,342,833.48
 营业利润(元) 47,963,754.5424,542,286.1023,548,071.6611,022,214.51
 利润总额(元) 47,617,519.2324,508,909.7423,411,968.1710,922,981.92
 净利润(元) 35,562,882.3718,311,158.0017,323,296.418,089,600.07
 归属母公司股东的净利润(元) 35,562,882.3718,311,158.0017,323,296.418,089,600.07
 非经常性损益(元) 475,165.55-22,620.74-109,323.02-75,404.06
 归属母公司股东的净利润扣除非经常性损益(元) 35,087,716.8218,333,778.7417,432,619.438,165,004.13
资产负债表摘要:
 流动资产(元) 456,349,688.91477,143,996.54476,839,439.28490,532,042.50
 固定资产(元) 1,361,321.751,564,401.131,820,588.84969,319.08
 资产总计(元) 462,999,411.17483,119,150.52481,679,925.25493,856,483.18
 流动负债(元) 269,352,575.91280,864,039.63297,735,972.36297,596,226.63
 负债合计(元) 269,352,575.91280,864,039.63297,735,972.36297,596,226.63
 股东权益(元) 193,646,835.26202,255,110.89183,943,952.89196,260,256.55
 归属母公司股东的权益(元) 193,646,835.26202,255,110.89183,943,952.89196,260,256.55
 资本公积(元) 9,881,401.829,881,401.829,881,401.829,881,401.82
 盈余公积(元) 21,078,545.9417,520,224.0217,520,224.0215,785,943.82
 未分配利润(元) 119,586,887.50131,753,485.05113,442,327.05127,492,910.91
现金流量表摘要:
 销售商品提供劳务收到的现金(元) 683,210,602.93330,989,186.62543,265,829.30247,595,749.53
 经营活动产生的现金净流量(元) 79,628,726.3812,750,818.547,573,021.47-31,984,957.51
 购建固定无形长期资产支付的现金(元) 47,649.00-1,238,791.202,998.98
 投资支付的现金(元) --26,000,000.0026,000,000.00
 投资活动产生的现金净流量(元) -47,649.00--1,221,425.51-2,991,368.50
 取得借款收到的现金(元) 240,000,000.00175,000,000.00264,730,000.00157,000,000.00
 筹资活动产生的现金净流量(元) -64,296,022.62-9,760,497.284,925,685.3353,747,194.35
 现金及现金等价物净增加(元) 15,285,054.762,990,321.2611,277,281.2918,770,868.34
 期末现金及现金等价物余额(元) 41,063,385.1928,768,651.6925,778,330.4333,271,917.48
 折旧与摊销(元) -274,212.55879,333.75213,385.15
公告日期 2024-04-222023-08-212023-04-262022-08-22
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院